170 related articles for article (PubMed ID: 15006609)
1. HSV-1 virions engineered for specific binding to cell surface receptors.
Grandi P; Wang S; Schuback D; Krasnykh V; Spear M; Curiel DT; Manservigi R; Breakefield XO
Mol Ther; 2004 Mar; 9(3):419-27. PubMed ID: 15006609
[TBL] [Abstract][Full Text] [Related]
2. HSV-1 amplicon peptide display vector.
Spear MA; Schuback D; Miyata K; Grandi P; Sun F; Yoo L; Nguyen A; Brandt CR; Breakefield XO
J Virol Methods; 2003 Jan; 107(1):71-9. PubMed ID: 12445940
[TBL] [Abstract][Full Text] [Related]
3. Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells.
Grandi P; Fernandez J; Szentirmai O; Carter R; Gianni D; Sena-Esteves M; Breakefield XO
Cancer Gene Ther; 2010 Sep; 17(9):655-63. PubMed ID: 20508670
[TBL] [Abstract][Full Text] [Related]
4. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
[TBL] [Abstract][Full Text] [Related]
5. Targeting HSV amplicon vectors.
Grandi P; Spear M; Breakefield XO; Wang S
Methods; 2004 Jun; 33(2):179-86. PubMed ID: 15121173
[TBL] [Abstract][Full Text] [Related]
6. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
[TBL] [Abstract][Full Text] [Related]
8. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein.
Wang X; Kong L; Zhang GR; Sun M; Geller AI
Brain Res Mol Brain Res; 2005 Sep; 139(1):88-102. PubMed ID: 15993510
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
12. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
13. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
Pechan PA; Fotaki M; Thompson RL; Dunn R; Chase M; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Oct; 7(16):2003-13. PubMed ID: 8930661
[TBL] [Abstract][Full Text] [Related]
14. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.
Herold BC; Visalli RJ; Susmarski N; Brandt CR; Spear PG
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1211-22. PubMed ID: 8207388
[TBL] [Abstract][Full Text] [Related]
16. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
17. Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion.
Yang T; Zhang GR; Zhang W; Sun M; Wang X; Geller AI
Brain Res Mol Brain Res; 2001 May; 90(1):1-16. PubMed ID: 11376851
[TBL] [Abstract][Full Text] [Related]
18. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
Gerber SI; Belval BJ; Herold BC
Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
[TBL] [Abstract][Full Text] [Related]
19. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
Herold BC; Spear PG
Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
[TBL] [Abstract][Full Text] [Related]
20. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
Logvinoff C; Epstein AL
Hum Gene Ther; 2001 Jan; 12(2):161-7. PubMed ID: 11177553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
